Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

31. Mai 2026 17:43 ET | Quelle: Hagens Berman Sobol Shapiro LLP

GOSS FINAL DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
29. Mai 2026 14:48 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– HBSS

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
27. Mai 2026 20:15 ET | Quelle: The Rosen Law Firm PA

GOSSAMER DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gossamer Bio, Inc. (NASDAQ: GOSS) between June 16, 2025 and...
27. Mai 2026 19:54 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– HBSS

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
25. Mai 2026 11:00 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– HBSS

financial statements are urged to contact Hagens Berman. Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial sta
22. Mai 2026 16:36 ET | Quelle: Hagens Berman Sobol Shapiro LLP

GOSS 10-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
21. Mai 2026 16:39 ET | Quelle: The Rosen Law Firm PA

GOSSAMER DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gossamer Bio, Inc. (NASDAQ: GOSS) between June 16, 2025 and...
19. Mai 2026 09:00 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure – Hagens Berman

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
15. Mai 2026 11:21 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– Hagens Berman

Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
13. Mai 2026 14:47 ET | Quelle: The Rosen Law Firm PA

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gossamer Bio, Inc. (NASDAQ: GOSS) between June 16, 2025 and...

Nächste Seite